LIVESTREAM: http://videoexchange.mayo.edu/webcasts 

Viewers who have access to Sharepoint can view live without VPN: https://mctools.sharepoint.com/teams/PEPS/VideoStreaming/

Christopher Klein, M.D.
"RNA and Chaperone Therapies Enter the Clinics for Devastating hATTR and Fabry"

Learning Objectives
Upon conclusion of this activity, participants will be able to:

• Demonstrate the application of migalastat chaperone therapy in Fabry disease
• Review knock down RNA hATTR therapies
• Recognize rapidly evolving targeted therapies for neuromuscular disorders

The presenter (and/or spouse/partner) has the following relevant financial relationships to disclose: Consultant - Akea, Pfizer, Alnylam, CMT therapeutics board; Grant/Research Support - Mayo Clinic Center for Individualized Medicine; Honoraria - University of Virginia, University of Chicago, University of Maryland, Johns Hopkins; Full-time/part-time employee - Mayo Clinic. He does not intend to discuss an off-label/investigative use of a commercial product/device.

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.